KalVista Pharmaceuticals, Inc. Quarterly Operating Lease, Liability, Current in USD from Q2 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
KalVista Pharmaceuticals, Inc. quarterly Operating Lease, Liability, Current history and growth rate from Q2 2019 to Q2 2024.
  • KalVista Pharmaceuticals, Inc. Operating Lease, Liability, Current for the quarter ending July 31, 2024 was $1.26M, a 12.7% increase year-over-year.
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.26M +$142K +12.7% Jul 31, 2024 10-Q 2024-09-05
Q1 2024 $1.3M +$215K +19.8% Apr 30, 2024 10-Q 2024-09-05
Q4 2023 $1.19M +$130K +12.3% Jan 31, 2024 10-Q 2024-03-11
Q3 2023 $1.15M +$122K +11.9% Oct 31, 2023 10-Q 2023-12-07
Q2 2023 $1.12M +$125K +12.5% Jul 31, 2023 10-Q 2023-09-07
Q1 2023 $1.09M +$110K +11.3% Apr 30, 2023 10-K 2024-07-11
Q4 2022 $1.06M +$43K +4.24% Jan 31, 2023 10-Q 2023-03-09
Q3 2022 $1.03M +$96K +10.3% Oct 31, 2022 10-Q 2022-12-08
Q2 2022 $997K +$92K +10.2% Jul 31, 2022 10-Q 2022-09-08
Q1 2022 $977K +$114K +13.2% Apr 30, 2022 10-K 2023-07-10
Q4 2021 $1.01M +$422K +71.3% Jan 31, 2022 10-Q 2022-03-10
Q3 2021 $930K +$508K +120% Oct 31, 2021 10-Q 2021-12-09
Q2 2021 $905K +$392K +76.4% Jul 31, 2021 10-Q 2021-09-09
Q1 2021 $863K +$275K +46.8% Apr 30, 2021 10-K 2022-07-07
Q4 2020 $592K $0 0% Jan 31, 2021 10-Q 2021-03-11
Q3 2020 $422K -$180K -29.9% Oct 31, 2020 10-Q 2020-12-10
Q2 2020 $513K -$67K -11.6% Jul 31, 2020 10-Q 2020-09-14
Q1 2020 $588K Apr 30, 2020 10-K 2021-07-13
Q4 2019 $592K Jan 31, 2020 10-Q 2020-03-10
Q3 2019 $602K Oct 31, 2019 10-Q 2019-12-03
Q2 2019 $580K Jul 31, 2019 10-Q 2019-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.